ARCHIVES

Ovarian Suppression Treatment Plus Tamoxifen Can Lower Recurrence Risk

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

NIH Balks At Forming New Review Groups For NCI’s Program Grants; Guidelines Draft Ready For NCAB

August 2, 1974

NCAB Considers Discrimination Against Patients, Minority Rates, Smokeless Tobacco

April 12, 1985

Tobacco Control: Surgeon General Finds Increase In Smoking By Minority Teens

May 1, 1998

NTP Board Approves $4 Million Mouse Variation Concept

November 22, 1985

Zevalin Regimen Effective In Mantle Cell Lymphoma

January 30, 2004

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

October 26, 2007